248 related articles for article (PubMed ID: 10811477)
1. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
O'Reilly MS
EXS; 1997; 79():273-94. PubMed ID: 9002223
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen.
Schmitz V; Wang L; Barajas M; Peng D; Prieto J; Qian C
Gene Ther; 2002 Dec; 9(23):1600-6. PubMed ID: 12424612
[TBL] [Abstract][Full Text] [Related]
5. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
[TBL] [Abstract][Full Text] [Related]
6. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
7. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
[TBL] [Abstract][Full Text] [Related]
8. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
9. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor growth with recombinant murine angiostatin.
Wu Z; O'Reilly MS; Folkman J; Shing Y
Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
14. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S; Palmer K; Gauldie J
Am J Pathol; 2001 Sep; 159(3):1137-47. PubMed ID: 11549607
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells.
Indraccolo S; Morini M; Gola E; Carrozzino F; Habeler W; Minghelli S; Santi L; Chieco-Bianchi L; Cao Y; Albini A; Noonan DM
Cancer Res; 2001 Jul; 61(14):5441-6. PubMed ID: 11454689
[TBL] [Abstract][Full Text] [Related]
18. [Effects of human plasminogen Kringle 5 gene therapy on pancreatic cancer].
Shi CQ; Li ZD; Zhang QH; Ni QX; Jin C; Zhang N; Song N
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1827-32. PubMed ID: 15631784
[TBL] [Abstract][Full Text] [Related]
19. Influence of adenoviral vector on expression of angiogenesis regulating factors in non-small cell lung cancer cell lines.
Kuhn H; Riedel A; Eichler W; Aust G; Gessner C; Wirtz H
Cancer Immunol Immunother; 2002 Oct; 51(8):461-6. PubMed ID: 12202907
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.
Ma HI; Lin SZ; Chiang YH; Li J; Chen SL; Tsao YP; Xiao X
Gene Ther; 2002 Jan; 9(1):2-11. PubMed ID: 11850717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
